Interventional, open-label, single-group, long-term follow-up trial of Lu AG22515 in patients with moderate-to-severe Thyroid Eye Disease
20453A
Phase 1 other active
Quick answer
Interventional, open-label, single-group, long-term follow-up trial of Lu AG22515 in patients with moderate-to-severe Thyroid Eye Disease for Active, moderate-to-severe TED is a Phase 1 program (other) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- H. Lundbeck A/S
- Indication
- Active, moderate-to-severe TED
- Phase
- Phase 1
- Modality
- other
- Status
- active